Untitled Document
OHSU Where Healing, Teaching and Discovery Come Together
OHSU Search OHSU OHSU Site Map Contact
OHSU Division of Hematology and Medical Oncology
About the Division Care Centers Patient Resources Our Faculty Research and Education News and Events
Dedicated to the study and treatment of cancer and disorders of the blood.

 
undefined

Our Faculty

Kathleen Kemmer, M.D.
Assistant Professor of Medicine

Specialty: Breast Cancer and Solid Tumor Medical Oncology

Clinic Phone: 503-494-6594
Office Phone: 503-494-8534
E-mail: kemmerk@ohsu.edu

 

Dr. Kemmer earned her medical doctorate at the University of Minnesota Medical School.  She then completed her residency at the University of Texas Southwestern Medical Center where she stayed on for one additional year as an Assistant Professor of Medicine.  She went on to complete her fellowship training at Oregon Health & Science University. Most recently, from 2003-2006, she practiced general hematology and oncology at the Annapolis Oncology Center with a focus on treating women with breast cancer and counseling high risk women. 

 
Appointments

  • Assistant Professor, School of Medicine, Department of Medicine, Hematology & Medical Oncology Division

 

Professional Education and Training

  • M.D., The University of Minnesota School of Medicine, Minneapolis, Minnesota, 1992-1996
  • Residency, The University of Texas Southwestern Medical School Affiliated Hospitals, Department of Medicine, Dallas, Texas, 1996-1999
  • Fellowship, Oregon Health & Science University, Hematology & Medical Oncology, Portland, Oregon, 2000-2003
Personal


 
Selected Publications

  • Kemmer K, Corless C, Fletcher J, Mcgreevey L, Haley A, Griffith D, Cummings O, Town A, and Heinrich M. KIT mutations are common in Testicular Seminomas. American Journal of Pathology 164:305-313, 2004. Also oral presentation and abstract at the AACR Annual Meeting, San Francisco, CA, April 9, 2002 and updated oral presentation and abstract at ASCO Molecular Therapeutics Meeting, San Diego, CA, November 8, 2002.
  • Madani A, Kemmer K, Sweeney C, Corless C, Ulbright T, Heinrich M, Einhorn L. Expression of KIT and epidermal growth factor receptor (EGFR) in chemotherapy refractory non-seminomatous germ cell tumors. Annals of Oncology 14:873-880, 2003.
  • Kruys V, Kemmer K, Shakhav A, Jongeneel V, and Beutler B. Constitutive activity of the tumor necrosis factor promoter is canceled by the 3’ untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect. Proc. Natl. Acad. Sci. 89(2): 673-677, 1992.
  • Serie J, Cooper H, Kemmer K, and Hegre O. Growth of neonatal islet transplants in the spontaneous diabetic BB/WOR rat. Diabetes 41(9): 1122-1129, 1992. (Also presented poster at International Diabetes Conference, Washington, D.C. 1991)